Stocks · Health care · Medicinal Chemicals & Botanical Products

Definium Therapeutics, Inc.

DFTX Clue Score37
United States Fiscal year ends December CIK 0001813814 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Matthew T. Wiley
25 Sep 2026
Chief Commercial Officer
Sold on a plan
3,097
$36.57
$113.26K
Robert Barrow
25 Sep 2026
Chief Executive Officer
Sold on a plan
31,550
$36.57
$1.15M
Daniel Karlin
25 Sep 2026
Chief Medical Officer
Sold on a plan
10,853
$36.57
$396.89K
Brandi Roberts
25 Sep 2026
Chief Financial Officer
Sold on a plan
3,377
$36.57
$123.50K
Mark Sullivan
25 Sep 2026
Chief Legal Officer
Sold on a plan
14,051
$36.57
$513.85K
Robert Barrow
3 Sep 2026
Chief Executive Officer
Sold on a plan
19,023
$37.94
$721.73K
Matthew T. Wiley
25 Jun 2026
Chief Commercial Officer
Sold on a plan
2,867
$45.03
$129.10K
Daniel Karlin
25 Jun 2026
Chief Medical Officer
Sold on a plan
10,035
$45.03
$451.88K
Robert Barrow
25 Jun 2026
Chief Executive Officer
Sold on a plan
29,208
$45.03
$1.32M
Brandi Roberts
25 Jun 2026
Chief Financial Officer
Sold on a plan
3,013
$45.03
$135.68K
Mark Sullivan
25 Jun 2026
Chief Legal Officer
Sold on a plan
13,008
$45.03
$585.75K
Robert Barrow
25 Mar 2026
Chief Executive Officer
Sold on a plan
24,431
$18.47
$451.24K
Mark Sullivan
25 Mar 2026
Chief Legal Officer
Sold on a plan
10,702
$18.47
$197.67K
Daniel Karlin
25 Mar 2026
Chief Medical Officer
Sold on a plan
8,018
$18.47
$148.09K
Mark Sullivan
26 Dec 2025
Chief Legal Officer
Sold on a plan
11,276
$13.15
$148.24K
Robert Barrow
26 Dec 2025
Chief Executive Officer
Sold on a plan
25,791
$13.15
$339.07K
Daniel Karlin
26 Dec 2025
Chief Medical Officer
Sold on a plan
5,600
$13.15
$73.62K
Daniel Karlin
25 Sep 2025
Chief Medical Officer
Sold on a plan
7,704
$9.77
$75.27K
Robert Barrow
25 Sep 2025
Chief Executive Officer
Sold on a plan
25,797
$9.77
$252.04K
Mark Sullivan
25 Sep 2025
Chief Legal Officer
Sold on a plan
11,278
$9.77
$110.19K
Robert Barrow
25 Jun 2025
Chief Executive Officer
Sold on a plan
26,491
$6.80
$180.14K
Daniel Karlin
25 Jun 2025
Chief Medical Officer
Sold on a plan
7,848
$6.80
$53.37K
Mark Sullivan
25 Jun 2025
Chief Legal Officer
Sold on a plan
11,491
$6.80
$78.14K
Carrie Liao
25 Mar 2025
Chief Accounting Officer
Sold on a plan
2,347
$6.74
$15.82K
Mark Sullivan
25 Mar 2025
Chief Legal Officer
Sold on a plan
6,576
$6.74
$44.32K
Daniel Karlin
25 Mar 2025
Chief Medical Officer
Sold on a plan
6,836
$6.74
$46.07K
Robert Barrow
25 Mar 2025
Chief Executive Officer
Sold on a plan
21,208
$6.74
$142.94K
Mark Sullivan
26 Dec 2024
Chief Legal Officer
Sold on a plan
4,519
$7.43
$33.58K
Daniel Karlin
26 Dec 2024
Chief Medical Officer
Sold on a plan
6,643
$7.43
$49.36K
Carrie Liao
26 Dec 2024
Chief Accounting Officer
Sold on a plan
2,273
$7.43
$16.89K
Robert Barrow
26 Dec 2024
Chief Executive Officer
Sold on a plan
19,106
$7.43
$141.96K
Mark Sullivan
25 Sep 2024
Chief Legal Officer
Sold on a plan
4,430
$5.98
$26.49K
Daniel Karlin
25 Sep 2024
Chief Medical Officer
Sold on a plan
6,871
$5.98
$41.09K
Robert Barrow
25 Sep 2024
Chief Executive Officer
Sold on a plan
19,771
$5.98
$118.23K
Carrie Liao
25 Sep 2024
Chief Accounting Officer
Sold on a plan
2,352
$5.98
$14.06K
Robert Barrow
25 Jun 2024
Chief Executive Officer
Sold on a plan
15,659
$7.22
$113.06K
Mark Sullivan
25 Jun 2024
Chief Legal Officer
Sold on a plan
17,854
$7.22
$128.91K
Daniel Karlin
25 Jun 2024
Chief Medical Officer
Sold on a plan
6,925
$7.22
$50.00K
Robert Barrow
25 Mar 2024
Chief Executive Officer
Sold on a plan
16,519
$9.50
$156.93K
Daniel Karlin
25 Mar 2024
Chief Medical Officer
Sold on a plan
6,578
$9.50
$62.49K

What was left out

Form 4 filings counted 160
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 40
Sales straight out of an exercise 0
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 12,496,357
Sales filed before the plan box existed 25
History held since 19 Jan 2022